Blood thinners after childbirth to prevent blood clots
Treatments studied
Part of Blood & lymphatic, Heart & circulation, Women’s health & pregnancy clinical trials.
This trial compares two blood-thinning medicines (apixaban and enoxaparin) to prevent dangerous blood clots after childbirth. If you are at higher risk for clots but not breastfeeding, you may be able to take part.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have recently given birth (either vaginally or by C-section).
- You have at least one high-risk factor (like active infection, heart disease, or an emergency C-section) OR two low-risk factors (like age over 35, C-section, BMI over 30, or smoking).
- You are not breastfeeding.
- You have not had a blood clot before, and no close family member has had one.
- You are not taking certain antidepressants (SSRIs or SNRIs) and have no history of bleeding disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a short course of a low-dose blood thinner (heparin) to prevent dangerous blood clots in the legs or lungs after childbirth. It is for women who have certain risk factors that make clots more likely.
This study looks at how a blood thinner called rivaroxaban enters breast milk after delivery. It may help women who need this medication while breastfeeding.
This study compares two blood-thinner medicines given after a C-section to see which one works better at preventing dangerous blood clots. It may help women who are at higher risk for clots rest easier right after delivery.
This study tests whether giving a short course of a daily blood-thinning injection (enoxaparin) after childbirth can safely prevent blood clots in women at intermediate risk. If you qualify, you would receive the injection or a placebo (inactive shot) for up to 5 days while in the hospital.
This trial tests if taking aspirin after delivery helps prevent dangerous blood clots in women with certain risk factors. It's for new mothers who have a clotting disorder, were on bed rest, or have multiple other risk factors like high weight or preeclampsia.
This trial tests whether a medication called apixaban (a blood thinner) can safely prevent blood clots after abdominal or pelvic surgery. It is for people who have a moderate risk of clots and bleeding, and who are not taking other blood thinners.
Hear when a new Postpartum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.